-
Sector Analysis
Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035
This report covers the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report provides an overview of the current treatment options, pipeline products in development, as well as current and future R&D trends. Key topics covered include a strategic competitive assessment of current and future drugs, unmet needs, KOL insights, and implications for the Systemic Sclerosis market. The base year of the sales forecast model is 2025, and the forecast period is 2025-2035. The diagnosed...
-
Sector Analysis
IDWeek 2026: Conference Highlights
The IDWeek Global Annual Meeting 2026 took place in Washington, DC, US from October 21–24. The IDWeek 2026 annual congress took place in Washington, DC, US, from October 21–24. GlobalData focused on scientific sessions where key therapies were featured and analyzed their contents to create this IDWeek 2026 Conference Highlights report.
-
CRO Activity and Intel Report Q3 2026
This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q3 2026.
-
Sector Analysis
Acne Vulgaris: Market View, Current and Future Competitive Landscape
This report provides a data-driven overview of the current and future competitive landscape in Acne Vulgaris Therapeutics. In 2025, there were more than 257.3 million diagnosed prevalent cases of Acne Vulgaris in the 16 countries covered in GlobalData’s epidemiology forecast. The AV market is mature, with treatment centered on topical retinoids, benzoyl peroxide (BPO), antibiotics, hormonal therapies, and fixed-dose combinations that simplify treatment and may improve adherence. Practice is shifting away from prolonged antibiotic monotherapy toward shorter courses, BPO co-prescription...
-
Product Insights
Metastatic Castration-Resistant Prostate Cancer (mCRPC): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Global Clinical Trials Review, 2026" provides an overview of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Castration-Resistant Prostate Cancer (mCRPC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
B-Cell Non-Hodgkin Lymphoma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma - Global Clinical Trials Review, 2026" provides an overview of B-Cell Non-Hodgkin Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) - Global Clinical Trials Review, 2026" provides an overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...
-
Product Insights
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2026" provides an overview of Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted...
-
Product Insights
Fragile X Syndrome: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Fragile X Syndrome - Global Clinical Trials Review, 2026" provides an overview of Fragile X Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Fragile X Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Dengue Fever: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Dengue Fever - Global Clinical Trials Review, 2026" provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.